Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if DEXCOM INC (NASDAQ:DXCM) is suited for growth investing. Investors should of course do their own research, but we spotted DEXCOM INC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.
Key Considerations for Growth Investors.
The Return on Equity(ROE) of DEXCOM INC is 16.62%, which is a strong number. This indicates the company's ability to generate favorable returns for shareholders and reflects its effective management of resources.
DEXCOM INC has a strong history of beating EPS estimates in the last 4 quarters, signaling its ability to consistently exceed market expectations. This indicates the company's strong financial performance and its potential for creating shareholder value.
With notable 1-year revenue growth of 21.85%, DEXCOM INC exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for future growth.
With impressive quarter-to-quarter (Q2Q) revenue growth of 26.69%, DEXCOM INC showcases its ability to generate increased sales and revenue. This growth indicates the company's strong customer demand and its effective business strategies.
DEXCOM INC has experienced notable growth in its operating margin over the past year, reflecting improved operational performance. This growth suggests the company's ability to generate higher profits from its core business activities.
DEXCOM INC has shown positive growth in its free cash flow (FCF) over the past year, indicating improved cash generation and financial strength. This growth highlights the company's ability to effectively manage its cash flows and generate surplus funds.
The quarterly earnings of DEXCOM INC have shown a 78.57% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
Analysts' average next Quarter EPS Estimate for DEXCOM INC has witnessed a 13.33% change in the last 3 months, underscoring the dynamic nature of market sentiment towards the company's EPS prospects.
The quarterly earnings of DEXCOM INC have shown a 78.57% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
The earnings per share (EPS) growth of DEXCOM INC are accelerating: the current Q2Q growth of 78.57% is above the previous year Q2Q growth of 25.84%. Earnings momentum and acceleration are key for high growth systems.
Fundamental Analysis Observations
ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.
DXCM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 201 industry peers in the Health Care Equipment & Supplies industry. DXCM has an excellent profitability rating, but there are some minor concerns on its financial health. DXCM is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, DXCM could be worth investigating further for growth investing!.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.